UK markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.0200-0.1700 (-7.76%)
At close: 04:00PM EDT
2.0100 -0.01 (-0.50%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 550.16M
Enterprise value 919.61M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.63
Price/book (mrq)0.85
Enterprise value/revenue 4.59
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3-84.53%
S&P500 52-week change 326.49%
52-week high 314.5500
52-week low 31.2500
50-day moving average 32.7208
200-day moving average 36.8955

Share statistics

Avg vol (3-month) 310.96M
Avg vol (10-day) 313.63M
Shares outstanding 5272.36M
Implied shares outstanding 6272.36M
Float 8270.9M
% held by insiders 11.85%
% held by institutions 194.56%
Shares short (30 Apr 2024) 452.82M
Short ratio (30 Apr 2024) 44.17
Short % of float (30 Apr 2024) 422.34%
Short % of shares outstanding (30 Apr 2024) 419.39%
Shares short (prior month 28 Mar 2024) 449.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -148.13%
Operating margin (ttm)-209.82%

Management effectiveness

Return on assets (ttm)-10.84%
Return on equity (ttm)-44.28%

Income statement

Revenue (ttm)200.43M
Revenue per share (ttm)0.77
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)N/A
EBITDA -282.54M
Net income avi to common (ttm)-296.9M
Diluted EPS (ttm)-1.1400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)561.91M
Total cash per share (mrq)2.06
Total debt (mrq)931.37M
Total debt/equity (mrq)143.50%
Current ratio (mrq)9.28
Book value per share (mrq)2.38

Cash flow statement

Operating cash flow (ttm)-240.16M
Levered free cash flow (ttm)-304.23M